This Lyrical Life: Music Therapy in Oncology

Quick, Dean; Yaguda, Susan

doi:10.1080/10463356.2021.1930440

Cited by 1 publication

(3 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similar to prior studies of MT with this population, patients in the HemOnc group had an average age of approximately 60 years 5,7,8 and were mostly female. 6-8 Patients with SCD were significantly younger (32 years) with a similar mean age to prior MT studies with this population.…”

Section: Discussionsupporting

confidence: 68%

“…This retrospective study highlights strengths of the UHSCC MT program including its (1) integration throughout the freestanding cancer center; (2) ability to provide services throughout patients' treatment journey; (3) clinical focus on adults with SCD; (4) ability to use technology to adapt services to new environments (eg, outpatient infusion and radiation) and the clinical challenges imposed at the beginning of the COVID-19 pandemic; and (5) demonstrated clinical effectiveness, particularly in reducing acute pain and anxiety. Similar to prior studies of MT with this population, patients in the HemOnc group had an average age of approximately 60 years 5,7,8 and were mostly female. [6][7][8] Patients with SCD were significantly younger (32 years) with a similar mean age to prior MT studies with this population.…”

Section: Discussionsupporting

confidence: 66%

“…3 A recent review of cancer center websites found that MT was available in 74.5% of National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and 55% of Community Hospitals. 4 Institutions including Atrium Health Levine Cancer Institute, 5 MD Anderson Cancer Center, 6 and Memorial Sloan Kettering Cancer Center 7,8 provide individualized and group MT services upon referral from the medical team and in collaboration with other integrative therapies including acupuncture, meditation, massage therapy, and art therapy. These services are delivered throughout the cancer center in both inpatient and outpatient settings.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Clinical Delivery and Effectiveness of Music Therapy in Hematology and Oncology: An EMMPIRE Retrospective Study

et al. 2022

View full text Add to dashboard Cite

Background: Music therapy (MT) has been shown to improve outcomes for patients with sickle cell disease (SCD) and patients with hematologic and/or oncologic conditions excluding SCD (HemOnc) in prior randomized trials. While few studies have described the clinical delivery (ie, volume, clinical settings, patient characteristics, referrals, and session characteristics) of MT and examined its real-world effectiveness, no studies have compared responses between hematology/oncology populations. The purpose of this study was to examine the clinical delivery and effectiveness of MT at a freestanding academic cancer center and compare the effectiveness of MT on pain, anxiety, and fatigue between adult patients in the HemOnc and SCD groups. Methods: A retrospective review was conducted of all MT sessions provided at a freestanding academic cancer center between January 2017 and July 2020. The unadjusted single-session effects of MT on pain, anxiety, and fatigue were assessed among patients reporting symptoms ≥1 out of 10 on a 0 to 10 scale. Adjustments were made for multiple sessions on the same patient using a mixed model to compare pre-session and change scores between the HemOnc and SCD groups. Patients’ comments were analyzed using conventional qualitative content analysis. Results: Music therapists provided 4002 sessions to 1152 patients including 1012 in the HemOnc group and 140 in the SCD group. In the combined sample, statistically significant reductions in pain (1.48 units), anxiety (2.58 units), and fatigue (0.84 units) were observed, with changes in pain and anxiety exceeding clinically significant thresholds. After adjustment, the SCD group reported significantly greater pre-session pain (7.22 vs 5.81) and anxiety (6.11 vs 5.17) as well as greater anxiety reduction (2.89 vs 2.23) than the HemOnc group. Patients’ comments contained themes including enjoyment, gratitude, and improvements in mood, pain, and anxiety. Conclusions: This study supports the delivery and clinical effectiveness of MT for addressing the needs of patients throughout their course of treatment at an academic cancer center and justifies the inclusion of individuals with SCD within integrative oncology services.

show abstract